Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction

This publication has 16 references indexed in Scilit:

• Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?
  Circulation, 1989
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials
  European Heart Journal, 1985
• Why do we need some large, simple randomized trials?
  Statistics in Medicine, 1984
• Thrombolytic Therapy
  New England Journal of Medicine, 1984
• Natural defense mechanisms during ischemia
  European Heart Journal, 1983
• Variability of electrocardiographic and enzyme evolution of myocardial infarction in man.
  Heart, 1981
• The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.
  Circulation, 1977
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
  British Journal of Cancer, 1977
• Limitations of myocardial revascularization in restoration of regional contraction abnormalities produced by coronary occlusion
  The American Journal of Cardiology, 1974